SynaptixBio awarded prestigious Innovate UK Grant. BioMedical Catalyst grant supports expanded search for rare disease therapies

A pioneering biotech firm has secured £13.2 million to fund its mission to develop the world’s first treatment for a rare, incurable and...

British biotech firm secures FDA rare paediatric disease designation in bid to develop world’s first treatment for incurable, deadly disease

Children with undiagnosed conditions urged to get checked for rare, incurable and deadly disease

We were delighted to welcome Sky News to Oxfordshire in November

The powerful story of Frankie Sheridan-Hill, aged seven, featured on ITV

Biotech firm enters into a pioneering new licence agreement in bid to develop world’s first treatment for deadly disease

‘Time running out’ in teen girl’s battle with TUBB4a leukodystrophy

Thousands of patients could unknowingly suffer with a rare life-threatening disease, experts have warned. TUBB4a leukodystrophy - an...

Mum diagnoses daughter's rare life-threatening disease

New biotech firm launched to develop ‘revolutionary’ new treatment for one of world’s rarest neurodegenerative diseases